Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030
PR Newswire —
Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Dec. 19, 2025 /PRNewswire/ -- USA News Group News Commentary – The recent FDA approval in November of the first bispecific antibody combination for second-line blood cancer treatment marks the departure from traditional chemotherapy...